삼성서울병원

Ko En

Choi, Doo Ho M.D

TITLE
Department of Radiation Oncology, Samsung Medical Center, Professor, Department of Radiation Oncology Sungkyunkwan University, School of Medicine
Treament Schedule 12 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
TUE
31
AM
PM
Treament Schedule 01 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical School

Seoul National University, College of Medicine

Specialty Training

Fellowship   Yale University Hospital, CT, USA
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Other Education

Master : Seoul National University , College of Medicine 1988
Ph.D : Korea University, College of Medicine 1995

Clinical & Research Interests

Breast Cancer
Colorectal Cancer
Special Radiation Therapy

Participation in Academic Societies
and Research

A member of the Korean Radiation Oncology Society
A member of the Korean Cancer Association
A member of the Korean Breast Cancer Society
A Member of the Korean Radiation Protection Society

Selected Publications

  • Breast Cancer Res Treat. 2017 Feb;162(1):77-83. doi: 10.1007/s10549-017-4111-1. Epub 2017 Jan 12. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02) Kim K11, Jung SY2, Shin KH3, Kim JH4, Han W5, Lee HB5, Huh SJ6, Choi DH6, Park W6, Ahn SD7, Kim SS7, Kim JH8, Suh CO9, Kim YB9, Kim IA4,10, Kim S4,11, Kim YJ1.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):1796-1804. doi: 10.18632/oncotarget.12882. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) Kim H11, Park W2, Yu JI2, Choi DH2, Huh SJ2, Kim YJ3, Lee ES3, Lee KS3, Kang HS3, Park IH3, Shin KH4, Kim K5, Park KR5, Kim YB6, Ahn SJ7, Lee JH8, Kim JH9, Chun M10, Lee HS11, Kim JS12, Lee JY13.
    View PubMed
  • Sci Rep. 2017 Jan 19;7:40922. doi: 10.1038/srep40922. Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation Oh D11, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.
    View PubMed
  • Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed